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ABSTRACT 
Objective: The present study gives emphasis on the development of self-nanoemulsifying drug delivery system (SNEDDS) of poorly water-soluble 
drug using Apelblat model.  
Methods: For the development of self-nanoemulsifying drug delivery system (SNEDDS) solubility in surfactant, co-surfactant and in oil phase are 
considered as an important key to avoid phase separation and precipitation after dilution. The solubility of quetiapine fumarate was determined by 
the isothermal mechanical shaking method for its individual components in the temperature range from 305.15 to 330.15K was measured. The 
experimental mole fraction solubility of quetiapine was good correlated with calculated data by using modified Apelblat model. Prepared SNEDDS 
were evaluated in centrifugation, freeze-thaw cycle study, self-nanoemulsification efficiency test. Physicochemical properties of prepared SNEDDS 
including particle size, zeta potential, viscosity and refractive index were carried out.  
Results: The equilibrium saturated and mole fraction solubility of Quetiapine fumarate was found to be high in tween80 than SNEDDS, Labrafac 
lipophile WL 1349 and capryol 90. Quetiapine fumarate equilibrium saturated solubility, as well as mole fraction solubility, was found to be 
increased with increase in temperature in SNEDDS as well as in its individual components Prepared SNEDDS was found to be highly stable at 
centrifugation, heating and cooling cycles and freeze-thaw cycles and shows no sign of precipitation after dilution in water. All physicochemical 
parameters were observed within specification including droplet size observed as 26.37 nm, polydispersity index 0.0970, zeta potential-14.69 and 
the refractive index was observed as 1.458 which was nearer to the refractive index of water indicating the isotropic behavior of prepared SNEDDS. 
Conclusion: The solubility study could be an effective approach for the development of thermodynamically stable SNEDDS formulation of poorly 
soluble drugs using Apelblat model. 
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Quetiapine fumarate is a psychotropic agent belonging to a chemical 
class of dibenzothiazepine derivatives. The chemical designation is 2-[2-
(4-dibenzo [b, f] [1, 4] thiazepin-11-yl-1-piperazinyl) ethoxy]-ethanol 
fumarate (2:1) (salt). Quetiapine fumarate has an empirical formula 
C42H50N6O4S2• C4H4O4 and molecular weight of 883.09. The 
biological life and bioavailability of QF is 6 h and 9%, respectively (1-6). 
Quetiapine Fumarate is a BCS class II drug. Quetiapine fumarate is a 
weak acid with dissociation constant (pKa) 3.3 and 6.8 with moderate 
pH-dependent solubility, 94.3 mg/ml to 2.37 mg/ml at pH values from 1 
to 9 reported. The main site for absorption for quetiapine fumarate is 
stomach as it exhibits very high solubility in gastric pH which falls 
drastically in intestinal pH. Thus, it would be more beneficial to retain 
quetiapine fumarate in the stomach (pH 1-3) for the prolonged duration 
to achieve maximum absorption and bioavailability [1-4].  
 
 
Fig. 1: Chemical structure of quetiapine fumarate 
 
The self-nanoemulsifying drug delivery system (SNEDDS), which 
involves an isotropic Mixture of drug, surfactants and oil, is 
emerging as a means of augmenting the oral Bioavailability of 
hydrophobic drugs. This system produces (nano) emulsions after 
contact with aqueous medium with the gastrointestinal fluid [5, 6]. 
These emulsion droplets are advantageous for drug absorption due 
to their large interfacial surface area, resulting in improved and 
reproducible bioavailability of poorly water-soluble drugs. SNEDDS 
is known to enhance the solubility of poorly soluble drugs, 
determination of drug solubility in surfactant, co-surfactant and in 
its oil phase and in SNEDDS is very essential The present paper 
focuses on the application of Thermodynamic based mathematical 
models for prediction of solubility of quetiapine fumarate in SNEDDS 
[7]. Thus the mole fraction solubility of quetiapine fumarate in 
prepared SNEDDS and its surfactant, cosurfactant and in oil phase 
components was predicted using empirical model equations and 
modified Apelblat model at the temperature range of 305.15 to 
330.15 K. This paper could illustrate the importance of mathematical 
modeling of solubility of poorly soluble drugs in SNEDDS in order to 
enhance solubility and oral bioavailability. The aim of this study was 
to provide a useful tool for mathematical modeling of poorly soluble 
drug in SNEDDS in order to enhance solubility, stability, dissolution 
and oral bioavailability. 
MATERIALS AND METHODS 
Materials  
Quetiapine fumarate was received as gift samples from Wanbury 
Pharmaceuticals Ltd. (Mumbai, India). Caprylic/Capric Triglyceride, 
(Labrafac liphophile WL) Propylene glycol monocaprylate, (capryol 
90)) was received as gift samples from Gattefosse (Mumbai, India). 
Tween 80 was purchased from Sigma Aldrich. All other chemicals 
and reagents were of highly purified grade and were used without 
further purification. All other chemicals used in the present study 
were of analytical reagent (AR grade). Their general properties are 
given in table 1. 
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Determination of quetiapine fumarate solubility in SMEDDS and 
its individual components 
The saturated solubility of quetiapine fumarate in Labrafaclipophile, 
tween 80, capryol 90 and prepared SMEDDS were determined by 
using mechanical shaking method [8, 9] at atmospheric pressure and 
a temperature range from 305.15 K-330.15 K. An excess amount of 
quetiapine fumarate was added in SNEDDS and its individual 
components in stoppered glass vials in triplicates. Each solid-liquid 
mixture vortexes properly to perform experiments. Each sample was 
then kept in a mechanical shaker at 100 RPM for 24 h to reach 
equilibrium. Each experiment was repeated at a temperature range 
from 305.15 K-330.15K. After 24 h, all samples were taken out and 
allowed to settle drug (solute) particles for 2 h at the bottom of the 
glass vials. All the samples were subjected to centrifugation at 
5000rpm for 15 min, supernatant from each sample was taken and 
diluted with methanol and subjected to analysis of quetiapine 
fumarate using UV-Visible spectrophotometer at 246.5 nm. From 
quetiapine fumarate content in each sample, equilibrium saturated 
solubility (mg/g) was determined. However, the experimental mole 
fraction solubility (xe) of quetiapine fumarate was calculated using 
equation 1: 
 
Where m1 is the mass of quetiapine fumarate (solute) and m2, m3 
and m4 are the mass of solvents (Labrafaclipophile, tween 80 and 
capryol 90, respectively). M1 represents the molecular mass of 
quetiapine fumarate and M2, M3 and M4 represent the molecular 
masses of Labrafaclipophile, tween 80 and capryol 90, respectively. 
 
Table 1: General properties of quetapine fumarate, oil, surfactant and co-surfactant 
Materials Molecular formula MW (g/Mol) D (g/ml) Chemical name 
Quetapine fumarate C42H50N6O4S2• 
C4H4O4 
883.11 - 2-[2-(4-dibenzo [b,f] [1,4]thiazepin-11-yl-piperazinyl)ethoxy]–ethanol 
Labrafac lipophile C16H26O5 298.37 0.93-0.96 Caprylic/Capric Triglyceride 
Tween 80 C64H124O26 1310 1.075 Polyoxyethylene (20) sorbitanmonooleate 
Capryol 90 C11H22O3 202.29 0.93-0.95 Propylene glycol monocaprylate 
 
Preparation of SNEDDS 
Various SNEDDS formulations of Quetiapine Fumarate were prepared 
by spontaneous emulsification technique via the construction of 
pseudoternary phase diagrams as reported previously 6. Equilibrated 
saturated solubility of quetapine fumarate as shown in table 4 was 
carried out using mechanical shaking method and optimum 
composition of SNEDDS as shown in table 2 was formulated [6]. 
An optimum formulation of SNEDDS for solubility modeling was 
obtained by taking the required amount of Labrafil-Liphophile in a 5 g 
capacity vial. The required amount of Tween-80 and Capryol 90 was 
added to oil phase and vortexed for 5 min. Finally, required amount of 
distilled water (aqueous phase) was added to a mixture of oil phase 
and surfactant phase in dropwise manner till clear and transparent 
blank SNEDDS (without drug) obtained as shown in table 2. 
 
Table 2: Composition of SNEDDS 
S. No. Formulation ingredients Composition (%w/w) 
1 Labrafac lipophile WL 1349 07.46 
2 Tween 80 27.86 
3 Capryol 90 14.92 
4 Distilled water 49.75 
 
RESULTS AND DISCUSSION 
Thermodynamic study and evaluation test 
Various SMEDDS formulations of quetiapine fumarate were 
developed and subjected to thermodynamic stability test to observe 
any phase separation, coalescence, creaming or conversion into the 
biphasic milky emulsion. Optimizes SNEDDS was selected for this 
study and was found to be highly stable at centrifugation, heating 
and cooling cycles and freeze-thaw cycles. Self-nano-emulsification 
efficiency test was carried out to evaluate signs of any precipitation 
or phase separation upon dilution with diluent. Distilled water was 
used as a diluent in this study. Prepared SNEDDS pass this test 
which indicated its suitability for SNEDDS. 
Physicochemical characterization of prepared SNEDDS 
The results of physicochemical characterization are listed in table 3. 
The mean particle size of prepared SNEDDS was observed as 26.37 nm 
with polydispersity index (PI) 0.0970. SNEDDS droplet size is a 
decisive point in the performance of self-emulsified formulations as it 
determines the rate and extent of drug release and absorption. Lowest 
value confirms its greatest absorption [6]. Polydispersability index 
below 0.3 indicates good uniformity in the globule size distribution 
after dilution with water. AS SNEDDS with increased globule size 
causes agglomeration of globules and suffers with the instability of the 
system [21]. The viscosity of SMEDDS was observed to be 0.890cp. 
Indicating short time of emulsification compared to those formulations 
with higher viscosity. Zeta potential of SNEDDS was found to be-
14.69mv which indicated the stable formation of SMEDDS. The 
negative value of zeta potential may be due to the presence of free 
fatty acids. A Negative value to the zeta potential of the optimized 
formulations indicated that the formulations were negatively charged, 
and sufficient repulsion among emulsion droplets existed to form an 
un-coagulated system and therefore, gives an indication of a stable 
system The Refractive Index (RI) of SNEDDS was observed at 1.458 
which was very nearer to RI of water (1.33). [6, 21] This indicated an 
isotropic behavior and o/w nature of prepared SNEDDS. Overall, all 
physicochemical parameters were found to suitable for SNEDDS. 
 
Table 3: Characterization of SNEDDS 
S. No. Characterization parameters Parameter value 
1 Droplet size (nm) 26.37±0.208 
2 PI 0.0970±0.0057 
3 Zeta potential (mv) -14.68±0.0057 
4 Viscosity (cp) 0.890±0.01 
5  RI 1.455±0.005 
The values are expressed as mean±SD; n=3, polydispersibility index (PI), refractive index (RI), 
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Solubility data of quetiapine fumarate 
The saturated equilibrium solubility of Quetiapine fumarate in 
Labrafac lipophile WL 1349, Tween 80, Capryol 90 and prepared 
SNEDDS at a temperature from 305 to 330 K are listed in table 4. 
The saturated equilibrium solubility of Quetiapine fumarate was 
found to be increased exponentially with increase in temperature in 
all sample matrices investigated. The saturated equilibrium 
solubility was observed highest in Tween 80 followed by Capryol 90, 
Labrafac lipophile WL1349 and SNEDDS as shown in table 6. 
 
Table 4: Equilibrium saturated solubility of quetapine fumarate in labrafac lipophile wl 1349, tween 80, capryol 90 and SNEDDS 
Sample Temperature (K) Solubility (mg/g)* 
Labrafaclipophile WL 1349 305.15 40.012±0.01 
 310.15 55.341±0.371 
 315.15 65.444±0.387 
 320.15 81.514±0.347 
 325.15 90.243±0.120 
 330.15 110.410±0.245 
Tween 80 305.15 115.000 
 310. 15 121.671±0.190 
 315. 15 130.046±0.080 
 320. 15 145.001±0.00 
 325. 15 170.140±0.080 
 330. 15 200.000 
Capryol 90 305. 15 58.000 
 310. 15 66.000 
 315. 15 75.445±0.145 
 320. 15 82.261±0.487 
 32515 99.998±0.001 
 330. 15 123.05±0.522 
SNEDDS 305. 15 30.716±0.160 
 310. 15 39.544±0.264 
 315. 15 48.816±0.104 
 320. 15 65.583±0.505 
 325. 15 82.593±0.531 
 330. 15 95.990±0.0577 
The values are expressed as mean±SD; n=3, self-Nano emulsifying drug delivery system (SNEDDS). 
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Fig. 3: Zeta Potential of SNEDDS 
 
Table 5: The modified apelblat model adjustable parameters for quetiapine fumarate in labrafac lipophile WL1349, tween-80, capryol 90 
and prepared SNEDDS 
Sample Apelblat model 
A B C R2 
Labrafaclipophile WL1349 717.95 -37108 -104.991 0.9919 
Tween 80 -742.17 33192 110.381 0.9987 
Capryol 90 -691.95 29835 103.108 0.9940 
SNEDDS 151.48 -11405 -21.121 0.9961 
 
Table 6: Equilibrium saturated solubility (S), mole fraction solubilities experimental (Xe) and calculated solubilities (xc) for quetiapine 
fumarate in labrafac lipophile labrafac lipophileWL1349, tween-80, tween 80, capryol 90 and prepared SNEDDS 
T/K S (mg/g)* (xc) 103xc (Xe)* 103xe* % AD 
Labrafac lipophile  
WL 1349 
305.15 40.012±0.01 0.01355 13.55 0.01326±0.00 13.26±0.00 -2.27 
310.15 55.341±0.371 0.01750 17.50 0.01825±0.001 18.25±0.001 4.19 
315.15 65.444±0.387 0.02110 21.10 0.02151±0.101 21.51±0.101 -1.40 
320.15 81.514±0.347 0.026300 26.30 0.02665±0.002 26.65±0.002 1.42 
325.15 90.243±0.120 0.030747 30.74 0.02942±0.001 29.42±0.001 -4.62 
330.15 110.410±0.245 0.034912 34.91 0.03576±0.020 35.76±0.020 2.44 
Tween 80  
305.15 115.000 0.14544 145.44 0.1450±0.030 145.0±0.030 -0.43 
310.15 121.671±0.190 0.15131 151.31 0.1525±0.0102 152.5±0.0102 1.065 
315.15 130.046±0.080 0.16174 161.74 0.1611±0.101 161.1±0.101 -0.422 
320.15 145.001±0.00 0.17731 177.31 0.1762±0.102 176.2±0.102 -0.848 
325.15 170.140±0.080 0.19904 199.04 0.2006±0.00 200.6±0.00 0.8110 
330.15 200.000 0.22845 228.45 0.2279±0.1012 227.9±0.1012 -0.189 
Capryol 90  
305.15 58.000 0.01321 13.21 0.013042±0.004 13.04±0.004 1.36 
310.15 66.000 0.01459 14.59 0.01482±0.102 14.82±0.102 -1.615 
315.15 75.445±0.145 0.01648 16.48 0.016894±0.001 16.89±0.001 -2.54 
320.15 82.261±0.487 0.01903 19.03 0.01845±0.203 18.45±0.203 -0.40 
325.15 99.998±0.001 0.02243 22.43 0.02227±0.402 22.27±0.402 0.77 
330.15 123.05±0.522 0.02694 26.94 0.02726±0.502 27.26±0.502 -1.20 
SNEDDS 
305.15 30.716±0.160 0.0119 11.9 0.0120±0.502 12±0.502 0.840 
310.15 39.544±0.264 0.0154 15.4 0.0155±0.101 15.5±0.101 0.645 
315.15 48.816±0.104 0.0197 19.7 0.0189±0.204 18.9±0.204 -4.232 
320.15 65.583±0.505 0.0249 24.9 0.0254±0.345 25.4±0.345 1.964 
325.15 82.593±0.531 0.0311 31.1 0.0321±0.405 32.1±0.405 3.11 
330.15 95.990±0.0577 0.0383 38.3 0.0375±0.407 37.5±0.407 -2.133 
*The values are expressed as mean±SD; n=3, calculated (xc), experimental (xe), (%AD). The percentage of absolute relative deviation. 
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Fig. 4: Experimental and calculated mole fraction solubilities of quetiapine fumarate in tween 80, capryol 90, labrafacliphophile WL 1349 
and self-nanoemulsifying drug delivery system (SNEDDS) at temperatures ranging from 300 to 335 K 
 
Thermodynamic modeling of solubility of quetiapine fumarate 
Numerous models including NRTL, UNIQUAC, UNIFAC, COSMOPACE, 
GEQUAC have been used to correlate experimental mole fraction 
solubility with theoretical mole fraction solubility [10-20]. As the 
modified Apelblat model is more accurate and reliable model it was 
selected for correlation of experimental and calculated data. 
According to the modified Apelblat model, the temperature-
dependent mole fraction solubilities of quetiapine fumarate at 
different temperatures can be calculated by the following equation:  
In Xe= A+B/T+CIn (T) 
Where  
Xe is the experimental mole fraction solubility of quetiapine fumarate 
T is the absolute temperature (k) 
A, B and C are adjustable parameters. 
The percentage of absolute relative deviation (%AD) of Quetiapine 
fumarate was determined by using following equation (2) 
%AD =Xe-Xc/Xe x 100 
Xe and Xc indicates experimental and calculated mole fraction 
solubilites of quetiapine fumarate respectively. Experimental mole 
fraction solubilities (Xe) and Apelblat model correlation of 
Quetiapine fumarate in Capryol 90 and in Labrafil Liphofile WL 
1349, Tween-80, and SNEDDS. are shown in fig. 4. The correlation 
coefficient value for quetiapine fumarate (R2) was obtained as 
0.9920,0.9987,0.9940,0.9961 for Labrafaclipophile WL 1349, Tween 
80, Capryol 90 and for SNEDDS as shown in table 6. 
Thus solubility data were interrelated by experimental values and 
calculated values from the modified Apelblat equation and shows 
appropriate to each other. 
CONCLUSION 
In this thermodynamic modelling approach, the equilibrium saturated 
solubility, as well as the mole fraction solubility of quetiapine fumarate 
in prepared SNEDDS and its individual components in the 
temperature range from 305.15to 330.15K, were measured. The 
solubility of quetiapine fumarate in surfactants tween 80 was found to 
be significantly higher than capryol 90, SNEDDS and labrafac 
liphophile WL1349. The solubility data of each experimental sample 
matrix were well correlated by the modified Apelblat model. The 
values of correlation coefficients (R2) in the range of 0.9960–0.9990 
showed that the modified Apelblat model provided a good fitting of 
experimental solubility data of quetiapine fumarate. These 
preliminary studies on solubility could be a useful tool for the 
development of an efficient and thermodynamically stable SNEDDS 
formulation of various poorly soluble drugs to enhance their stability, 
solubility, dissolution and oral bioavailability. 
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